Good manufacturing practice production of [(68)Ga]Ga-ABY-025 for HER2 specific breast cancer imaging.

Irina Velikyan(Uppsala University), Jens Christian Hedemann Sørensen(Uppsala University), Joachim Feldwisch(Uppsala University), Henrik Lindman(Uppsala University), Anders Wennborg(Affibody (Sweden)), Jörgen Carlsson(Uppsala University Hospital)

PubMed

January 1, 2016

Cited by 24

Related Papers

Breast Cancer in Young Women: Poor Survival Despite Intensive Treatment

|PLoS ONE|2009|504

Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial

|The Lancet|2000|343

Prospective of <sup>68</sup>Ga-Radiopharmaceutical Development

|Theranostics|2014|306

Measuring HER2-Receptor Expression In Metastatic Breast Cancer Using [<sup>68</sup>Ga]ABY-025 Affibody PET/CT

|Theranostics|2015|269

First-in-Human Molecular Imaging of HER2 Expression in Breast Cancer Metastases Using the <sup>111</sup>In-ABY-025 Affibody Molecule

|Journal of Nuclear Medicine|2014|260